Upon IFN-γ stimulation, both WT-VHL and Mut-VHL ccRCC cells activate the IRF-1α site of the PD-L1 promoter via the JAK2/STAT1 signaling pathway, thereby enhancing PD-L1 expression. Here, IFNG is linked to nonpapillary renal cell carcinoma.